Literature DB >> 17287961

Spatial dose distributions in solid tumors from 186Re transported by liposomes using HS radiochromic media.

Luis A Medina1, Beth Goins, Mercedes Rodríguez-Villafuerte, Ande Bao, Arnulfo Martínez-Davalos, Vibhudutta Awasthi, Olga O Galván, Cristina Santoyo, William T Phillips, María-Ester Brandan.   

Abstract

PURPOSE: A procedure for the measurement of spatial dose rate distribution of beta particles emitted by 186Re-liposomes in tumoral tissue, using HS GafChromic films, is presented.
METHODS: HNSCC xenografts were intratumorally injected with 3.7 or 11.1 MBq of 186Re-liposomes, and planar gamma camera images were acquired to determine the liposome retention in the tumor. After imaging, rats were sacrificed and tumors were excised and processed in slices; HS film sections were placed between slices and the tumor lobe was reassembled. Tumors and films were kept in the dark at 4 degrees C for 18 h. After irradiation, films were removed and response was read using a transmission scanner. Films were analyzed to determine two-dimensional spatial dose rate distributions and cumulative dose volume histograms. Dose rate distributions were quantified using a 60Co calibration curve, the 186Re physical half-life, and a perturbation factor that takes into account the effect of the film protective layer.
RESULTS: Dose rate distributions are highly heterogeneous with maximal dose rates about 0.4 Gy h(-1) in tumors injected with 3.7 MBq and 1.3 Gy h(-1) in tumors injected with 11.1 MBq. Dose volume histograms showed dose distributed in more than 95% and 80% of the tumor when injected with the lower and the higher activity, respectively.
CONCLUSION: The described procedures and techniques have shown the potential and utility of HS GafChromic film for determination of dose rate distributions in solid tumors injected intratumorally with 186Re-liposomes. The film's structure and the liposomes' biodistribution must be taken into account to obtain quantitative dose measurements.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287961     DOI: 10.1007/s00259-006-0297-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   10.057


  23 in total

Review 1.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

Authors:  D C Drummond; O Meyer; K Hong; D B Kirpotin; D Papahadjopoulos
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

Review 2.  Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical development.

Authors:  K J Harrington; C R Lewanski; J S Stewart
Journal:  Clin Oncol (R Coll Radiol)       Date:  2000       Impact factor: 4.126

3.  The use of a reflective scanner to study radiochromic film response.

Authors:  H Alva; H Mercado-Uribe; M Rodríguez-Villafuerte; M E Brandan
Journal:  Phys Med Biol       Date:  2002-08-21       Impact factor: 3.609

4.  Low dose fraction behavior of high sensitivity radiochromic film.

Authors:  E Y Hirata; C Cunningham; J A Micka; H Keller; M W Kissick; L A DeWerd
Journal:  Med Phys       Date:  2005-04       Impact factor: 4.071

5.  Theoretical study of the influence of a heterogeneous activity distribution on intratumoral absorbed dose distribution.

Authors:  Ande Bao; Xia Zhao; William T Phillips; F Ross Woolley; Randal A Otto; Beth Goins; James M Hevezi
Journal:  Med Phys       Date:  2005-01       Impact factor: 4.071

6.  Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model.

Authors:  K J Harrington; G Rowlinson-Busza; K N Syrigos; R G Vile; P S Uster; A M Peters; J S Stewart
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

7.  Liposome-mediated radiotherapeutics within avascular tumor spheroids: comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibody.

Authors:  Dimitris Emfietzoglou; Kostas Kostarelos; Alexandros Papakostas; Wei-Hong Yang; Ase Ballangrud; Hong Song; George Sgouros
Journal:  J Nucl Med       Date:  2005-01       Impact factor: 10.057

8.  An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy.

Authors:  D Emfietzoglou; K Kostarelos; G Sgouros
Journal:  J Nucl Med       Date:  2001-03       Impact factor: 10.057

Review 9.  Tumour therapy with radionuclides: assessment of progress and problems.

Authors:  Jörgen Carlsson; Eva Forssell Aronsson; Sven Ola Hietala; Torgny Stigbrand; Jan Tennvall
Journal:  Radiother Oncol       Date:  2003-02       Impact factor: 6.280

10.  Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides.

Authors:  J A O'Donoghue; M Bardiès; T E Wheldon
Journal:  J Nucl Med       Date:  1995-10       Impact factor: 10.057

View more
  1 in total

1.  Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery system.

Authors:  Azadeh Kheirolomoom; Dustin E Kruse; Shengping Qin; Katherine E Watson; Chun-Yen Lai; Lawrence J T Young; Robert D Cardiff; Katherine W Ferrara
Journal:  J Control Release       Date:  2009-09-11       Impact factor: 9.776

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.